Claims for Patent: 7,700,275

Summary for Patent: 7,700,275

Title:	Detection system
Abstract:	A method for detecting the presence of a target nucleic acid sequence in a sample, said method comprising: performing nucleic acid amplification on the sample in the presence of (a) a DNA duplex binding agent, (b) a nucleic acid polymerase and (c) a reagent comprising an amplification primer which can hybridize to said target sequence when in single stranded form and which is connected at its 5\' end to a probe which carries a label by way of a chemical linking group, said labeled probe being of a sequence which is similar to that of the said target nucleic acid sequence, such that it can hybridize to a complementary region in an amplification product, and wherein the label is able to absorb fluorescence from or donate fluorescent energy to the DNA duplex binding agent; and monitoring fluorescence of said sample.
Inventor(s):	Lee; Martin Alan (Salisbury, GB)
Assignee:	The Secretary of State of Defense (Salisbury, Witshire, GB)
Application Number:	10/478,788
Patent Claims:	1. A method for detecting the presence of a target nucleic acid sequence in a sample, the method comprising: performing nucleic acid amplification on the sample in the presence of (a) a DNA duplex binding agent in an unbound state, (b) a nucleic acid polymerase and (c) a reagent comprising an amplification primer which can hybridise to the target sequence when in single stranded form and which is connected at its 5' end to a probe which carries a label by way of a chemical linking group, the labelled probe being of a sequence such that the labelled probe hybridizes to a complementary region in an amplification product, and wherein the label is able to absorb fluorescence from or donate fluorescent energy to the DNA duplex binding agent; and monitoring fluorescence of the sample. 2. The method of claim 1, said method comprising: (a) adding to a sample suspected of containing the target nucleic acid sequence, the DNA duplex binding agent in an unbound state, the nucleic acid polymerase and the reagent; (b) subjecting said sample to conditions under which the primer hybridises to the target nucleic acid sequence and an amplification product comprising the probe is formed; (c) subjecting said sample to conditions under which the labelled probe hybridises to a complementary region in the amplification product; and (d) monitoring fluorescence of said sample during at least one of steps (b) and (c). 3. The method of claim 1 wherein the amplification product comprises the probe. 4. The method of claim 1 wherein the DNA duplex binding agent is an intercalating dye. 5. The method of claim 1 wherein the DNA duplex binding agent comprises a donor label and the probe comprises the acceptor label. 6. The method of claim 1 wherein the DNA duplex binding agent comprises an acceptor label and the probe comprises the donor label. 7. The method of claim 1 wherein the acceptor label is a fluorescent molecule which emits energy at a characteristic wavelength. 8. The method of claim 7 wherein the acceptor label is a rhodamine dye or Cy5. 9. The method of claim 1 wherein the acceptor label is a dark acceptor. 10. The method of claim 9 wherein the dark acceptor is DABCYL, Methyl Red, a QSY-7 diarylrhodamine dye or 6-(dimethylamino)-2-[4-[4-(dimethylamino)p-henyl]-1,3-butadienyl]-1-ethyl quinolinium perchlorate. 11. The method of claim 1 wherein the amplification reaction comprises a polymerase chain reaction. 12. The method of claim 1 wherein the acceptor molecule is a fluorescent molecule and wherein fluorescence of both the donor and the acceptor molecules are monitored and the relationship between the emissions calculated. 13. The method of claim 1 wherein the fluorescent signal from the sample is monitored throughout the amplification reaction and the results used to quantitate the amount of target sequence present in the sample. 14. The method of claim 1 wherein the amplification reaction is performed in the presence of an additional corresponding amplification primer which is not attached to a labelled probe. 15. A method for detecting nucleic acid amplification comprising: performing nucleic acid amplification on a target polynucleotide in the presence of (a) a nucleic acid polymerase, (b) a DNA duplex binding agent in an unbound state and (c) a reagent comprising an amplification primer which can hybridise to the target sequence when in single stranded form and which is connected at its 5' end to a probe which carries a second label, by way of a chemical linking group, the labelled probe being a sequence that can hybridise to a complementary region in an amplification product, and wherein one of the DNA duplex binding agent or second label comprises a donor label which is able to donate fluorescent energy to the other of the DNA duplex binding agent or second label which comprises an acceptor label able to absorb fluorescent energy from the donor molecule, the primer being capable of hybridizing to the target polynucleotide; and monitoring changes in fluorescence during the amplification reaction. 16. The method of claim 15 wherein the amplification is carried out using a pair of primers which are designed such that only the target nucleotide sequence within a DNA strand is amplified. 17. The method of claim 1 wherein the probe is specific either for a splice region of RNA or an intron in DNA, so that only one of amplified RNA or amplified DNA is detected and/or quantitated.

Details for Patent 7,700,275

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2021-05-25
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2021-05-25
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2021-05-25